-
![NOVEL UREA 6,7-DIHYDRO-4H-PYRAZOLO[4,3-C]PYRIDINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)](/abs-image/US/2022/01/13/US20220009922A1/abs.jpg.150x150.jpg)
1.发明申请公开(公告)号：US20220009922A1
公开(公告)日：2022-01-13
申请号：US17290354
申请日：2019-11-01
发明人： Alastair DONALD , Andreas URBAN , Susanne BONSMANN
IPC分类号： C07D471/04 , A61P31/20
摘要： The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
公开(公告)号：US20220306647A1
公开(公告)日：2022-09-29
申请号：US17607605
申请日：2020-04-29
IPC分类号： C07D498/04 , C07D487/04 , C07D471/04 , C07D471/14
摘要： The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
![NOVEL UREA 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)](/abs-image/US/2022/01/13/US20220009931A1/abs.jpg.150x150.jpg)
3.发明申请公开(公告)号：US20220009931A1
公开(公告)日：2022-01-13
申请号：US17290541
申请日：2019-11-01
发明人： Alastair DONALD , Andreas URBAN , Susanne BONSMANN
IPC分类号： C07D487/04
摘要： The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
![NOVEL 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)](/abs-image/US/2022/11/17/US20220363686A1/abs.jpg.150x150.jpg)
公开(公告)号：US20220363686A1
公开(公告)日：2022-11-17
申请号：US17290357
申请日：2019-11-01
IPC分类号： C07D487/04 , A61P31/20
摘要： The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
![NOVEL UREA 6,7-DIHYDRO-4H-THIAZOLE[5,4-C]PYRIDINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)](/abs-image/US/2022/01/13/US20220009945A1/abs.jpg.150x150.jpg)
5.发明申请公开(公告)号：US20220009945A1
公开(公告)日：2022-01-13
申请号：US17290504
申请日：2019-11-01
发明人： Alastair DONALD , Andreas URBAN , Susanne BONSMANN
IPC分类号： C07D513/04
摘要： The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
公开(公告)号：US20220227789A1
公开(公告)日：2022-07-21
申请号：US17607428
申请日：2020-04-29
IPC分类号： C07D519/00 , C07D498/04 , A61P31/20
摘要： The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
公开(公告)号：US20220227785A1
公开(公告)日：2022-07-21
申请号：US17607634
申请日：2020-04-29
IPC分类号： C07D498/04 , C07D487/04 , C07D471/14 , C07D471/04
摘要： The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
![NOVEL UREA 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)](/abs-image/US/2021/11/18/US20210355129A1/abs.jpg.150x150.jpg)
8.发明申请公开(公告)号：US20210355129A1
公开(公告)日：2021-11-18
申请号：US17290417
申请日：2019-11-01
发明人： Alastair DONALD , Andreas URBAN , Susanne BONSMANN
IPC分类号： C07D487/04 , A61P31/12
摘要： The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
公开(公告)号：US20220227737A1
公开(公告)日：2022-07-21
申请号：US17607430
申请日：2020-04-29
发明人： Susanne BONSMANN , Alastair DONALD , Andreas URBAN , Thomas GOLDNER , Miquel Angel PERICAS BRONDO , Esther Alza BARRIOS , Elena DETTA , Justine RAYMOND
IPC分类号： C07D403/06 , C07D405/12 , C07D403/12 , A61P31/20
摘要： The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
![6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)](/abs-image/US/2022/03/17/US20220081444A1/abs.jpg.150x150.jpg)
10.发明申请公开(公告)号：US20220081444A1
公开(公告)日：2022-03-17
申请号：US17290347
申请日：2019-11-01
IPC分类号： C07D487/04 , A61P31/20 , C07D519/00
摘要： The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
-
-
-
-
-
-
-
-
搜索结果
11 条记录 (耗时 0.048 秒)
